CytoDyn Inc.
11/22/2024 | Press release | Distributed by Public on 11/22/2024 16:16
Proxy Results Form 8 K
Item 5.07 Submission of Matters to a Vote of Security Holders.
CytoDyn Inc. (the "Company") held its 2024 Annual Meeting of Stockholders (the "Annual Meeting") on November 22, 2024. On November 22, 2024, the Inspector of Election issued its final report certifying the final voting results for the Annual Meeting, which were as follows:
1.Election of Directors.
|
|
|
|
||||
|
Nominee |
|
For |
|
Withheld |
|
Broker Non-Votes |
|
Tanya Durkee Urbach |
|
324,668,950 |
|
62,148,477 |
|
247,674,869 |
|
Stephen M. Simes |
|
359,999,216 |
|
24,818,211 |
|
247,674,869 |
|
Ryan M. Dunlap |
|
362,080,939 |
|
24,736,488 |
|
247,674,869 |
|
Lishomwa C. Ndhlovu, M.D., Ph.D. |
|
360,175,478 |
|
26,641,949 |
|
247,674,869 |
|
Karen J. Brunke, Ph.D. |
|
360,021,777 |
|
26,795,650 |
|
247,674,869 |
The stockholders elected each of the Company's director nominees to serve until the Company's 2025 annual meeting of stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal.
2. Ratification of Appointment of Independent Registered Public Accounting Firm
|
For |
|
Against |
|
Abstentions |
Broker Non-Votes |
|
619,778,908 |
9,126,390 |
5,586,998 |
-0- |
The stockholders voted to ratify the selection of Marcum LLP as the Company's independent registered public accounting firm for the fiscal year ending May 31, 2025.
3. Advisory vote on compensation of named executive officers.
|
|
|
||||
|
For |
|
Against |
|
Abstentions |
Broker Non-Votes |
|
315,973,038 |
63,214,010 |
7,630,379 |
247,674,869 |
The stockholders approved, on an advisory basis, the compensation paid to the Company's named executive officers.